Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Greenwich LifeSciences (GLSI) Non-cash Items (2021 - 2022)

Greenwich LifeSciences filings provide 2 years of Non-cash Items readings, the most recent being $2.0 million for Q4 2022.

  • Quarterly Non-cash Items rose 32.71% to $2.0 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2022, up 32.71% year-over-year, with the annual reading at $2.0 million for FY2022, 32.71% up from the prior year.
  • Non-cash Items hit $2.0 million in Q4 2022 for Greenwich LifeSciences, roughly flat from $2.0 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $2.0 million in Q3 2022 and bottomed at $1.5 million in Q4 2021.